These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26319244)

  • 1. HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.
    Annema W; Dikkers A; de Boer JF; Dullaart RP; Sanders JS; Bakker SJ; Tietge UJ
    J Am Soc Nephrol; 2016 Feb; 27(2):595-603. PubMed ID: 26319244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL Cholesterol Efflux Predicts Incident New-Onset Diabetes After Transplantation (NODAT) in Renal Transplant Recipients Independent of HDL Cholesterol Levels.
    Szili-Torok T; Annema W; Anderson JLC; Bakker SJL; Tietge UJF
    Diabetes; 2019 Oct; 68(10):1915-1923. PubMed ID: 31375510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.
    Kopecky C; Ebtehaj S; Genser B; Drechsler C; Krane V; Antlanger M; Kovarik JJ; Kaltenecker CC; Parvizi M; Wanner C; Weichhart T; Säemann MD; Tietge UJ
    J Am Soc Nephrol; 2017 Mar; 28(3):769-775. PubMed ID: 27612996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of the antioxidative function of HDL for cardiovascular disease and graft failure in renal transplant recipients.
    Leberkühne LJ; Ebtehaj S; Dimova LG; Dikkers A; Dullaart RP; Bakker SJ; Tietge UJ
    Atherosclerosis; 2016 Jun; 249():181-5. PubMed ID: 27107804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study.
    Liu C; Zhang Y; Ding D; Li X; Yang Y; Li Q; Zheng Y; Wang D; Ling W
    Atherosclerosis; 2016 Jun; 249():116-24. PubMed ID: 27088866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
    Khera AV; Cuchel M; de la Llera-Moya M; Rodrigues A; Burke MF; Jafri K; French BC; Phillips JA; Mucksavage ML; Wilensky RL; Mohler ER; Rothblat GH; Rader DJ
    N Engl J Med; 2011 Jan; 364(2):127-35. PubMed ID: 21226578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipients.
    Singh N; Jacobs F; Rader DJ; Vanhaecke J; Van Cleemput J; De Geest B
    J Heart Lung Transplant; 2014 May; 33(5):499-506. PubMed ID: 24630408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction.
    Guerin M; Silvain J; Gall J; Darabi M; Berthet M; Frisdal E; Hauguel-Moreau M; Zeitouni M; Kerneis M; Lattuca B; Brugier D; Collet JP; Lesnik P; Montalescot G
    J Am Coll Cardiol; 2018 Dec; 72(25):3259-3269. PubMed ID: 30573028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels.
    Annema W; Willemsen HM; de Boer JF; Dikkers A; van der Giet M; Nieuwland W; Muller Kobold AC; van Pelt LJ; Slart RH; van der Horst IC; Dullaart RP; Tio RA; Tietge UJ
    J Clin Lipidol; 2016; 10(6):1318-1328. PubMed ID: 27919348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
    Ronsein GE; Hutchins PM; Isquith D; Vaisar T; Zhao XQ; Heinecke JW
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):404-11. PubMed ID: 26681752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study.
    Roos M; Baumann M; Liu D; Heinemann FM; Lindemann M; Horn PA; Türk T; Lutz J; Heemann U; Witzke O; von Eynatten M
    Regul Pept; 2012 Oct; 178(1-3):11-5. PubMed ID: 22750635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL cholesterol efflux capacity and incident cardiovascular events.
    Rohatgi A; Khera A; Berry JD; Givens EG; Ayers CR; Wedin KE; Neeland IJ; Yuhanna IS; Rader DR; de Lemos JA; Shaul PW
    N Engl J Med; 2014 Dec; 371(25):2383-93. PubMed ID: 25404125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.
    Rogacev KS; Zawada AM; Emrich I; Seiler S; Böhm M; Fliser D; Woollard KJ; Heine GH
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2120-7. PubMed ID: 25060791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux in the transplant patient.
    Sudharshan S; Javaheri A
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):143-146. PubMed ID: 29337706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
    Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
    Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
    Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL subfractions distribution in renal transplant recipients: lack of evidence of a reduction of HDL2 particles.
    Barbagallo CA; Averna MR; Sparacino V; Cefalù AB; Caputo F; Noto D; Verghi F; Notarbartolo A
    Nephron; 1996; 72(3):407-12. PubMed ID: 8852488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: a FIELD substudy.
    Maranghi M; Hiukka A; Badeau R; Sundvall J; Jauhiainen M; Taskinen MR
    Atherosclerosis; 2011 Nov; 219(1):259-65. PubMed ID: 21696738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosis.
    Yamamoto S; Narita I; Kotani K
    Clin Chim Acta; 2016 Jun; 457():117-22. PubMed ID: 27087419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.